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INTRODUCTION 
MATERIALS AND METHODOLOGY 
OBJECTIVES 
Type 2 diabetes is a metabolic disorder characterized by insulin resistance, insulin 
action and caused by multifactorial etiology, including environmental factors, 
particularly diet and genetic components. Recently, most research on diabetes has 
focus on adipocyte which is used as a model for testing of insulin sensitivity and 
novel antidiabetic drugs. Adipose tissue is the major fat depot of the body and an 
important endocrine organ which plays a major role in energy regulation and 
homeostasis. The differentiation and proliferation of pre-adipocyte (adipogenesis) is 
required to maintain the ‘healthy’ functions of adipose tissue[1]. It has been reported 
that peroxisome proliferator-activated receptor (pparγ) and glucose transport (glut4) 
performs a key role in lipid and glucose metabolism [2].  
 
To evaluate the in vitro activities of cycloartane triterpenoid on adipocyte 
differentiation, glucose uptake and related gene expression (pparγ and glut4) 
mechanism on adipocytes.  
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Fig. 7: 2-Deoxyglucose uptake analysis 
The present study can provide a supportive information for a further study 
on the in vivo method using diabetic-induced animal and control group. 
Later, the compound can be commercialized as an alternative treatment for 
the management of diabetes and  its related diseases. 
It can be concluded that cycloartane triterpenoid follow almost similar pattern to that of insulin 
in adipocyte differentiation. In addition, it can effectively stimulate the peripheral glucose uptake 
at dose 50 µM. Through the quantitative RT-PCR evaluation, these findings suggest that 
cycloartane triterpenoid enhance adipocyte differentiation and glucose uptake by stimulation of 
PPARγ and GLUT4 expression. 
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Pparγ activation in mature adipocytes regulates several genes involved in the 
insulin signaling cascade and glucose and lipid metabolism [3]. Since the 
incidence of diabetes and the resultant metabolic syndrome are rapidly increasing, 
this has opened the gap to search for an alternative therapy from natural products 
which can stimulate adipocyte differentiation, enhance blood glucose uptake, 
easily available and cost effective. 
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Fig. 8: Pparγ binding 
activity 
Fig. 9: Glut4 expression 
Figure 8: Effect of cycloartane triterpenoid on pparγ binding activity. Pparγ expression 
was measured after 48 hours of treatment. B-actin was used as the control. Results are 
expressed as means ± SD. 
Figure 9: Glut4 expression. Glut4 is the major insulin-dependent transporter 
responsible for the uptake of glucose from blood stream into muscle and fat. 
Before induction, 3T3-L1 preadipocyte were free from any lipid droplets. Cell treated 
with different concentration of the compound significantly enhance conversion of 
preadipocyte into mature adipocyte (adipocyte differentiation). The formation of lipid 
droplets and OD value which were significant with insulin (positive control) further 
supported this observation. 
Figure 5: Effects of cycloartane triterpenoid on adipocyte differentiation. The Oil Red O 
stained adipocyte were photographed at magnification of 200x. 
Figure 6: The intracellular fat accumulation increased by 1.9 fold relative to MDI-
treated cells at concentration 50 µM.  All values are presented as means ± SD of three 
independent experiments. *p < 0.05 vs. untreated group (DMSO control). 
Figure 7: Glucose uptake assay. Adipocyte in 12-well plates were incubated for 60 
minutes with cycloartane triterpenoid (50 µM) or with metformin (1mM) and sodium 
orthovanadate (5mM) as a positive control, or without treatment as a negative control. 
Levels of radioactivity in the cell lysates were determined using a liquid scintillation 
counter. Data are means ± SD, (n = 3). *p < 0.01 vs. untreated group (DMSO control). 
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